Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Diabetes Res Clin Pract 213:111745 Svensson AM, Toll A, Lebrec J, Miftaraj M, Franzn S, Eliasson B (2021) Treatment persistence in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists in clinical practice in Sweden
T2DM is a leading risk factor for PAD, which limits physical functions
Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration
doi:10.1016/S0168-0102(00)00124-3
The study indicated that the treatment of low dose selenite led to a just marginal increase in GPx activity in NIH3T3, MCF-7, and Sup-T1 cells, whereas identical treatment led to ~ fivefold increase of GPx activity in PC12 and AA8 cells
10.1097/sla.0000000000004457 11 BendottiG.MontefuscoL.LunatiM
US$ 23.08
US$ 20.57
US$ 24.73
US$ 26.66
US$ 24.18
